Results 181 to 190 of about 5,401 (225)

Phototoxic Irritant and Burning Sensation Following the Topical Application of Pimecrolimus Cream

Journal of clinical pharmacology, 2022
Ze‐Yu Luo, Shao-Wen Feng, Cheng Lei, Di-Qing Luo   +3 more
semanticscholar   +1 more source

Pimecrolimus in dermatology.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009
Pimecrolimus is a non-steroidal immunosuppressant derived from ascomycin. This drug inhibits the action of calcineurin phosphatase and blocks the production of inflammatory substances that are thought to be important in causing skin lesions in inflammatory diseases.
C. Fabroni, LOTTI, TORELLO
openaire   +2 more sources

Pimecrolimus

Reactions Weekly, 2008
  +4 more sources

Pimecrolimus

Reactions Weekly, 2009
openaire   +1 more source

Pimecrolimus

Reactions Weekly, 2018
openaire   +2 more sources

Pimecrolimus

Reactions Weekly
  +4 more sources

Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study

Clinical drug investigation, 2019
Wen-ting Hu, Yongping Xu, Yang-Yang Ma, Jiehao Lei, Fu-Quan Lin, Ai-e Xu   +5 more
semanticscholar   +1 more source

Pimecrolimus

Reactions Weekly, 2015
openaire   +2 more sources

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug

Journal of Allergy and Clinical Immunology, 2002
Kim A. Papp, Alexander Kapp, Carle Paul
exaly  

Pimecrolimus

Reactions Weekly, 2021
openaire   +1 more source